site background
Skip to content
Ivy Brain Tumor Center
Main Menu
  • ESPAÑOL
  • Donate
  • Blog
  • TRIAL ELIGIBILITY
Talk to an Ivy Navigator
  • Brain Tumor Care
    • Tumor Types
      • Glioblastoma
      • Gliomas
      • Brain Metastases
      • Meningiomas
      • Other Tumors
    • Brain Tumor Treatment
      • Neurosurgery
      • Neuro-Oncology
      • Radiation Oncology
      • Neuroimaging
    • Supportive Care
      • Neuro-Rehabilitation
      • Neuropsychology
      • Palliative Care
      • Support Groups
      • Social Work Services
  • Clinical Trials
    • Current Trials
    • Phase 0 Clinical Trials
    • Trial Screening
  • Our Specialists
  • Patient & Caregiver Resources
    • Advocacy & Support Groups
    • Patient & Visitor Information
      • Lodging
      • Transportation
    • Patient Stories
    • Blog
  • Research
    • Scientific Cores
    • Labs
    • Certifications
    • Preclinical Research
    • Industry Partnerships
    • Published Research
  • About
    • Newsroom
    • Careers
    • How You Can Help
    • Events
    • Contact Us

Talk to an Ivy Navigator

602-406-8605
About Team Shwetal Mehta, PhD
Headshot of Shwetal Metah

Shwetal Mehta, PhD

Deputy Director and Pre-Clinical Core Leader

Dr. Shwetal Mehta received her Master’s Degree from Tata Institute of Fundamental Research, India, in Molecular Biology. She then earned her PhD in Molecular Genetics and Microbiology from The University of Texas at Austin in 2003.  She completed her postdoctoral work in the Stiles Laboratory at the Dana-Farber Cancer Institute and Harvard Medical School. Her postdoctoral work was focused on the identification of a potential therapeutic target for high-grade gliomas.

As Deputy Director of the Ivy Brain Tumor Center, Dr. Mehta is a recognized leader in translational science for brain tumors and has helped develop an array of early-phase pharmacodynamic- and pharmacokinetic-driven studies for patients with malignant brain tumors.  As a Principal Investigator within the Ivy Center, her expertise in molecular biology and the signaling pathways driving glioma biology is essential to our Phase 0 clinical trials program.

Back to Top
St Joesph Hospital

Stay Informed

Stay up to date on the latest in brain tumor research, treatment and community events.

Ivy Brain Tumor Center

About Ivy Brain Tumor Center

The Ivy Brain Tumor Center at Barrow Neurological Institute in Phoenix, AZ, is a tertiary care and nonprofit translational research program that employs bold, early-phase clinical trial strategies to identify new treatments for aggressive brain tumors, including glioblastoma. Our leading experts in neurosurgical oncology, neuro-oncology, radiation oncology, neuroradiology, neuropathology and neuroscience nursing treat more patients annually than any other brain tumor center in the United States. The Ivy Center’s Phase 0 clinical trials program is the largest in the world and enables personalized care in a fraction of the time and cost associated with traditional drug development. In addition, unlike conventional clinical trials focusing on single drugs, the Ivy Center’s accelerated program tests therapeutic combinations matched to individual patients. We leave no stone unturned in the pursuit of hope and healing.

Follow Us

  • Facebook
  • Twitter
  • Instagram
  • LinkedIn
  • YouTube

2910 North Third Avenue
Phoenix, Arizona 85013
(602) 406-6489
[email protected]
Mailing Address for Donations »

Barrow Neurological Institute

HIPAA Notice of Privacy Practices  |  Legal Notices  | Internet Privacy Notice  |  Online Accessibility Notice  |  Organized Health Care Arrangement (OHCA)

Patient Rights and Responsibilities  |  Site Map

© 2024 Ivy Brain Tumor Center

Important Notice

To give you the best possible experience, this site uses cookies and by continuing to use the site you agree that we can save them on your device.